Pharmacokinetics of IL-23p19 Inhibitors: A Systematic Review Across Immune-Mediated Inflammatory Diseases
Ilse A Pool, Alise D E de Groot, Ron J Keizer, Marla C Dubinsky, Joana Torres, Raja Atreya, Paul Malik, Erwin Dreesen, Gerard Dijkstra, Henkjan J Verkade, Paola Mian, Arno R Bourgonje · 2026
Read Pharmacokinetics of IL-23p19 Inhibitors: A Systematic Review Across Immune-Mediated Inflammatory Diseases by Ilse A Pool, Alise D E de Groot, Ron J Keizer, Marla C Dubinsky, Joana Torres, Raja Atreya, Paul Malik, Erwin Dreesen, Gerard Dijkstra, Henkjan J Verkade, Paola Mian, Arno R Bourgonje (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623995.txt.
Description
Ilse Pool and eleven co-authors review in 2026 how a class of immune drugs moves through the body. The drugs block one part of a signal protein and treat bowel, skin, and joint inflammation. Nearly half of patients respond poorly, in part because drug levels vary from person to person.
The team gathered twenty-one studies on four drugs of this class. Most covered healthy adults or skin and joint disease; only one looked at children with bowel disease. For the best-studied drug, levels and clearance looked alike across bowel diseases. Levels rose over repeat doses in bowel patients but fell in others. The gaps show where more level checks are due.
Catalog record
| CREATOR | Ilse A Pool, Alise D E de Groot, Ron J Keizer, Marla C Dubinsky, Joana Torres, Raja Atreya, Paul Malik, Erwin Dreesen, Gerard Dijkstra, Henkjan J Verkade, Paola Mian, Arno R Bourgonje |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |